China DMF Prices Fall 2% in late April 2026 Amid Post-Peak Correction

China DMF Prices Fall 2% in late April 2026 Amid Post-Peak Correction

Ian Fleming 07-May-2026

China's DMF market shifted from a broadly bullish April into a late-month pullback, as robust end-use demand met intermittent supply frictions before easing at month-end. Early April saw firmer upstream dynamics and targeted buying from pharmaceutical and textile supply chains. Mid-month activity, boosted by increased binder-solvent dosing at a Sichuan lithium-ion gigafactory and larger synthetic-leather imports through Haiphong, provided additional support. By late April, however, participants scaled back short-term bids and speculative activity cooled, leaving sentiment steady-to-firmer but with a weekly correction in the closing week. Sector demand remained the primary price driver, with pharmaceuticals and agro-pharma providing the strongest pull as DMF continued to serve antibiotics, anti-tumor drug and pesticide-intermediate production. That resilient demand underpinned a notable month-on-month rise. The lithium-ion binder segment and Vietnamese synthetic-leather imports contributed incremental volumes, while upstream tightness in methanol and concentrated dimethylamine supported pricing power. Outlook suggests continued modest upward pressure into next week, tempered by regional stock coverage and potential feedstock relief.

China&#xx;s dimethylformamide (DMF) market moved from a broadly bullish April into a late-month pullback, as robust end-use demand met intermittent supply frictions before easing in the final days. Early April saw firmer upstream dynamics and targeted buying from pharmaceutical and textile supply chains. By late April, however, DMF market players scaled back some short-term bids and speculative activity cooled, leaving sentiment steady-to-firmer overall but with a short-lived weekly correction in the closing week.

DMF Sector demand remained the primary price driver through April, with pharmaceuticals and agro-pharma providing the strongest pull as DMF continued to serve essential roles in antibiotics, anti-tumor drug and pesticide-intermediate production. That rigid demand underpinned a notable month-on-month rise, our analysts calculate a xx.xx increase from the prior month, moving DMF to $xxx/MT in April xxxx from $xxx/MT previously.

Upstream feedstock pressure was central to DMF pricing dynamics. Tighter...

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.